Eugene Athan

Eugene Athan

Auto-generated profile, based on publicly available information

Eugene Athan

Department of Infectious Diseases, Barwon Health , Geelong, Victoria

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2005 in JAMA
Verified
Journal Article
Open access
PDF file
VFVance G Fowler
Vance G Fowler
JMJose M. Miro
Jose M. Miro
BHBruno Hoen
Bruno Hoen
CCChristopher H. Cabell
Christopher H. Cabell
EAElias Abrutyn
Elias Abrutyn
FIfor the ICE Investigators
for the ICE Investigators
For decades, infective endocarditis (IE) caused by Staphylococcus aureus has been viewed primarily as a community-acquired disease, especially associated with injection drug use.1-7 In contrast, patients with nosocomial or intravascular catheter–associated S aureus bacteremia were considered to be at low risk for IE.5,6,8-11S aureus IE is relatively infrequent at any individual institution, and observations of its characteristics were based primarily upon relatively small samples,1,3,6,9,12-14 single-center experiences,5,6,8,9,13-16 or retrospectively identified patients.2,7,8,15,16 Patient characteristics, treatment practices, and outcomes in these single-center studies often differed considerably. Moreover, because no large, prospectively collected, and geographically diverse cohort of patients with IE existed before now, the impact of regional variations on the characteristics, treatment, and outcome of S aureus IE was unknown.

28 March 2007 in JAMA
Verified
Journal Article
Open access
PDF file
AWAndrew Wang
Andrew Wang
EAEugene Athan
Eugene Athan
PPPaul A. Pappas
Paul A. Pappas
VFVance G. Fowler
Vance G. Fowler
LOLars Olaison
Lars Olaison
CCChristopher H. Cabell
Christopher H. Cabell
Heart valve replacement surgery is performed in more than 150 000 patients per year in the United States and Europe,1,2 and the number of prosthetic valve implantations continues to increase.3 Infection of a heart valve prosthesis, or prosthetic valve endocarditis (PVE), is an uncommon but potentially lethal complication of heart valve replacement surgery. Despite advances in its diagnosis and treatment, PVE is associated with substantial morbidity and mortality.4-8 Prosthetic valve endocarditis has been estimated to occur at a rate of 0.3% to 1% per patient-year and to account for 1% to 5% of all cases of infective endocarditis (IE).9-12

13 January 2015 in Circulation
Verified
Journal Article
Closed access
VCVivian H. Chu
Vivian H. Chu
LPLawrence P. Park
Lawrence P. Park
EAEugene Athan
Eugene Athan
FDFrancois Delahaye
Francois Delahaye
TFTomas Freiberger
Tomas Freiberger
AWAndrew Wang
Andrew Wang
Background—: Use of surgery for the treatment of infective endocarditis (IE) as related to surgical indications and operative risk for mortality has not been well defined. Methods and Results—: The International Collaboration on Endocarditis–PLUS (ICE-PLUS) is a prospective cohort of consecutively enrolled patients with definite IE from 29 centers in 16 countries. We included patients from ICE-PLUS with definite left-sided, non–cardiac device–related IE who were enrolled between September 1, 2008, and December 31, 2012. A total of 1296 patients with left-sided IE were included. Surgical treatment was performed in 57% of the overall cohort and in 76% of patients with a surgical indication. Reasons for nonsurgical treatment included poor prognosis (33.7%), hemodynamic instability (19.8%), death before surgery (23.3%), stroke (22.7%), and sepsis (21%). Among patients with a surgical indication, surgical treatment was independently associated with the presence of severe aortic regurgitation, abscess, embolization before surgical treatment, and transfer from an outside hospital. Variables associated with nonsurgical treatment were a history of moderate/severe liver disease, stroke before surgical decision, and Staphyloccus aureus etiology. The integration of surgical indication, Society of Thoracic Surgeons IE score, and use of surgery was associated with 6-month survival in IE. Conclusions—: Surgical decision making in IE is largely consistent with established guidelines, although nearly one quarter of patients with surgical indications do not undergo surgery. Operative risk assessment by Society of Thoracic Surgeons IE score provides prognostic information for survival beyond the operative period. S aureus IE was significantly associated with nonsurgical management.

19 February 2008 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
JBJ. W. Baddley
J. W. Baddley
DBD. K. Benjamin
D. K. Benjamin
MPM. Patel
M. Patel
JMJ. Miró
J. Miró
EAE. Athan
E. Athan
Natividad BenitoNatividad Benito
Natividad Benito

15 January 2008 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
VCVivian H. Chu
Vivian H. Chu
CWChristopher W. Woods
Christopher W. Woods
JMJose M. Miro
Jose M. Miro
BHBruno Hoen
Bruno Hoen
CCChristopher H. Cabell
Christopher H. Cabell
IGInternational Collaboration on Endocarditis-Prospective Cohort Study Group
International Collaboration on Endocarditis-Prospective Cohort Study Group
Background. Coagulase-negative staphylococci (CoNS) are an infrequent cause of native valve endocarditis (NVE), and our understanding of NVE caused b

1 May 2015 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
Monica SlavinMonica Slavin
Monica Slavin
SHSebastiaan Van Hal
Sebastiaan Van Hal
TSTania Christine Sorrell
Tania Christine Sorrell
ALA. Lee
A. Lee
DMD.J. Marriott
D.J. Marriott
SCSharon Chen
Sharon Chen